Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azeliragon in mild to moderate Alzheimer's disease
NCT00566397Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azeliragon in Alzheimer's disease (AD), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
azeliragon
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00566397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566397.